- Home
- UNF vs AKRO Comparison
UNF vs AKRO Comparison
Compare UNF & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNF
- AKRO
- Stock Information
- Founded
- UNF 1936
- AKRO 2017
- Country
- UNF United States
- AKRO United States
- Employees
- UNF N/A
- AKRO N/A
- Industry
- UNF Business Services
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- UNF Consumer Discretionary
- AKRO Health Care
- Exchange
- UNF Nasdaq
- AKRO Nasdaq
- Market Cap
- UNF 3.1B
- AKRO 3.7B
- IPO Year
- UNF N/A
- AKRO 2019
- Fundamental
- Price
- UNF $151.81
- AKRO $54.05
- Analyst Decision
- UNF Sell
- AKRO Buy
- Analyst Count
- UNF 4
- AKRO 10
- Target Price
- UNF $174.75
- AKRO $73.56
- AVG Volume (30 Days)
- UNF 169.2K
- AKRO 4.3M
- Earning Date
- UNF 10-22-2025
- AKRO 11-07-2025
- Dividend Yield
- UNF 0.92%
- AKRO N/A
- EPS Growth
- UNF 2.70
- AKRO N/A
- EPS
- UNF 7.98
- AKRO N/A
- Revenue
- UNF $2,432,352,000.00
- AKRO N/A
- Revenue This Year
- UNF $4.26
- AKRO N/A
- Revenue Next Year
- UNF $4.77
- AKRO N/A
- P/E Ratio
- UNF $19.02
- AKRO N/A
- Revenue Growth
- UNF 0.20
- AKRO N/A
- 52 Week Low
- UNF $150.32
- AKRO $21.34
- 52 Week High
- UNF $243.70
- AKRO $58.40
- Technical
- Relative Strength Index (RSI)
- UNF 37.29
- AKRO 68.15
- Support Level
- UNF $150.32
- AKRO $53.40
- Resistance Level
- UNF $156.91
- AKRO $54.31
- Average True Range (ATR)
- UNF 6.00
- AKRO 0.23
- MACD
- UNF -0.88
- AKRO -0.21
- Stochastic Oscillator
- UNF 6.04
- AKRO 71.82
About UNF Unifirst Corporation
UniFirst Corp provides workplace uniforms, protective clothing, and other workplace products and services to businesses in the United States, Canada, and Europe. The U.S. and Canadian Rental and Cleaning segment that accounts for the majority of the company engages in sales rents and sells clothing and non-garment items, and offers a cleaning service that delivers clean uniforms when it picks up dirty or contaminated ones. Manufacturing segment designs and manufactures uniforms and non-garment items. Specialty garments rental and cleaning segment provides specialty garments, non-garments, and cleaning services for nuclear and classroom applications. The First Aid segment provides safety supplies and pill packaging. The Corporate segment consists of various associated costs.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.